2484
D.A. Androsov et al. / Tetrahedron 66 (2010) 2474–2485
(CDCl3)
d
1.26 (t, J¼7.2 Hz, 6H), 3.40 (q, J¼7.2 Hz, 4H), 5.97 (s, 1H),
(dd, J¼8.7, 2.4 Hz, 1H), 8.25 (d, J¼2.4 Hz, 1H); 13C NMR (CDCl3)
7.58 (d, J¼8.4 Hz, 1H), 7.81 (dd, J¼8.4, 2.1 Hz, 1H), 8.18 (d, J¼2.1 Hz,
d
14.2, 47.8, 61.9, 97.4, 115.5, 115.8, 121.7, 138.4, 141.1, 145.9, 154.7,
169.7; m/z (EI) 280 (Mþ, 30%), 207 (100), 161 (34), 134 (10); HRMS
(EI) calcd for C12H12N2O4S [Mþ] 280.0519, found 280.0519.
1H); 13C NMR (CDCl3)
d 12.4, 47.0, 94.2, 114.08, 114.13, 121.3, 137.7,
142.1, 145.9, 157.9; m/z (EI) 250 (Mþ, 66%), 235 (100), 207 (25), 189
(23), 161 (20); HRMS (ESI) calcd for C12H15N2O2S [MþH]þ 251.0850,
found 251.0854.
4.4.21. N-(2-(1H-Indol-3-yl)ethyl)-5-nitrobenzo[b]thiophen-2-amine
(14u). Purified by column chromatography (SiO2, CHCl3/MeOH
(100:1)). Yellow crystals, 0.20 g (23%), mp 160–161 ꢀC. 1H NMR
4.4.15. N,N-Dibutyl-5-nitrobenzo[b]thiophen-2-amine
(14o). Purified by column chromatography (SiO2, CHCl3/Hexane
(1:2)). Red crystals, 0.21 g (33%), mp 45–46 ꢀC. 1H NMR (CDCl3)
(CDCl3)
d
3.15 (t, J¼6.5 Hz, 2H), 3.57 (q, J¼6.5 Hz, 2H), 4.35 (br t,
J¼5.3 Hz, 1H), 6.13 (s, 1H), 7.08 (d, J¼2.4 Hz, 1H), 7.13–7.18 (m, 1H),
7.21–7.27 (m, 1H), 7.40 (d, J¼7.8 Hz, 1H), 7.57 (d, J¼8.7, Hz, 1H), 7.62
(d, J¼7.8 Hz, 1H), 7.86 (dd, J¼8.7, 2.4 Hz, 1H), 8.09 (br s, 1H), 8.20 (d,
d
1.00 (t, J¼7.4 Hz, 6H), 1.35–1.47 (m, 4H), 1.63–1.73 (m, 4H), 3.34 (t,
J¼7.5 Hz, 4H), 5.95 (s, 1H), 7.59 (d, J¼8.4 Hz, 1H), 7.82 (dd, J¼8.4,
2.1 Hz, 1H), 8.20 (d, J¼2.1 Hz, 1H); 13C NMR (CDCl3)
d
13.9, 20.2,
J¼2.4 Hz, 1H); 13C NMR (CDCl3)
d 25.0, 46.9, 96.5, 111.4, 112.5, 115.0,
29.3, 53.2, 94.0, 114.0, 114.1, 121.3, 137.6, 142.2, 145.9, 158.6; m/z (EI)
306 (Mþ, 46%), 263 (44), 221 (100), 207 (22), 191 (7), 175 (16), 161
(27), 57 (47); HRMS (ESI) calcd for C16H23N2O2S [MþH]þ 307.1473,
found 307.1480.
115.2, 121.6, 122.3, 122.5, 127.2, 136.5, 138.2, 141.5, 145.9, 156.3; m/z
(EI) 337 (Mþ, 8%), 207 (7), 143 (8), 130 (100); HRMS (EI) calcd for
C18H15N3O2S [Mþ] 337.0885, found 337.0882.
4.4.22. 2,6-Dimethyl-1-(5-nitrobenzo[b]thiophen-2-yl)piperidine
(14v). Purified by column chromatography (SiO2, CHCl3/Hexane
(1:2), (1:1)). Orange crystals, 0.38 g (63%), mp 98–99 ꢀC. 1H NMR
4.4.16. N,N-Di-iso-propyl-5-nitrobenzo[b]thiophen-2-amine
(14p). Purified by column chromatography (SiO2, CHCl3/Hexane
(1:2)). Red crystals, 0.15 g (33%), mp 85–86 ꢀC. 1H NMR (CDCl3)
(CDCl3)
d
1.19 (d, J¼6.9 Hz, 6H),1.58–1.62 (m, 3H),1.82–1.85 (m, 3H),
d
1.35 (d, J¼7.5 Hz, 12H), 3.85 (heptet, J¼6.9 Hz, 2H), 6.17 (s, 1H),
3.50–3.54 (m, 2H), 6.35 (s,1H), 7.66 (d, J¼8.7 Hz,1H), 7.91 (dd, J¼8.7,
7.58 (d, J¼8.7 Hz, 1H), 7.82 (dd, J¼8.7, 2.1 Hz, 1H), 8.21 (d, J¼2.1 Hz,
2.4 Hz, 1H), 8.30 (d, J¼2.4 Hz, 1H); 13C NMR (CDCl3)
d 17.0, 19.5, 31.8,
1H); 13C NMR (CDCl3)
d
20.5, 51.2, 98.3, 114.4, 121.1, 137.7, 141.4,
54.5, 102.3, 115.5, 115.7, 121.9, 139.8, 140.4, 145.7, 159.4; m/z (EI) 290
(Mþ, 33%), 275 (100), 81 (15), 55 (65); HRMS (ESI) calcd for
C15H19N2O2S [MþH]þ 291.1164, found 291.1167.
145.8, 156.2; m/z (EI) 278 (Mþ, 56%), 263 (70), 221 (100), 194 (20),
175 (26), 148(20), 121 (11); HRMS (ESI) calcd for C14H19N2O2S
[MþH]þ 279.1162, found 279.1167.
4.4.23. 2-(1-(5-Nitrobenzo[b]thiophen-2-yl)piperidin-2-yl)ethanol
(14w). Purified by column chromatography (SiO2, CHCl3/MeOH
(100:1)). Red-orange crystals, 0.127 g (20%), mp 114–115 ꢀC. 1H
4.4.17. N-(Cyclopropylmethyl)-5-nitro-N-propylbenzo[b]thiophen-2-
amine (14q). Purified by column chromatography (SiO2, CHCl3/
Hexane (1:2)). Red crystals, 0.23 g (38%), mp 48–49 ꢀC. 1H NMR
NMR (CDCl3)
d 1.53–1.75 (m, 5H), 1.80–1.92 (m, 2H), 2.01–2.08 (m,
(CDCl3)
d
0.29 (q, J¼4.8 Hz, 2H), 0.58–0.64 (m, 2H), 0.97 (t, J¼7.4 Hz,
1H), 3.12–3.27 (m, 1H), 3.47–3.51 (m, 1H), 3.71–3.76 (m, 2H), 3.97–
3H), 1.07–1.19 (m, 1H), 1.73 (heptet, J¼7.5 Hz, 2H), 3.23 (d, J¼6.6 Hz,
4.03 (m, 1H), 6.18 (s, 1H), 7.59 (d, J¼8.4 Hz, 1H), 7.84 (dd, J¼8.4,
2H), 3.38 (t, J¼7.7 Hz, 2H), 6.00 (s, 1H), 7.57 (d, J¼8.7 Hz, 1H), 7.81
2.4 Hz, 1H), 8.20 (d, J¼2.4 Hz,1H); 13C NMR (CDCl3)
d 18.7, 24.7, 27.4,
(dd, J¼8.7, 2.1 Hz, 1H), 8.18 (d, J¼2.1 Hz, 1H); 13C NMR (CDCl3)
d
3.9,
31.1, 45.7 55.5, 60.2, 96.5, 114.76, 114.79, 116.7, 121.5, 124.9, 138.9,
141.6, 145.8, 159.9; m/z (EI) 306 (Mþ, 22%), 289 (14), 261 (100), 215
(23); HRMS (ESI) calcd for C15H19N2O3S [MþH]þ 307.1108, found
307.1116.
9.3, 11.4, 20.3, 54.7, 57.7, 94.4, 114.17, 114.20, 121.3, 137.6, 142.1, 145.9,
158.7; m/z (EI) 290 (Mþ, 11%), 261 (9), 207 (10), 55 (100); HRMS
(ESI) calcd for C15H19N2O2S [MþH]þ 291.1157, found 291.1167.
4.4.18. N-Benzyl-N-methyl-5-nitrobenzo[b]thiophen-2-amine
(14r). Purified by column chromatography (SiO2, CHCl3/Hexane
(1:2), (1:1), (2:1)). Red crystals, 0.25 g (41%), mp 82 ꢀC. IR (neat):
3085, 3022, 2918, 1598, 1535, 1494, 1443, 1417, 1328, 1306, 1246,
1193, 1165, 1137, 1092, 1058, 1030, 1002, 987, 942, 917, 874, 823, 807,
4.4.24. 1-Methyl-4-(5-nitrobenzo[b]thiophen-2-yl)piperazine
(14x). Purified by column chromatography (SiO2, CHCl3/MeOH
(40:1)). Yellow crystals, 0.43 g (74%), mp 139–140 ꢀC. 1H NMR
(CDCl3) d 2.38 (s, 3H), 2.58–2.62 (m, 4H), 3.33–3.36 (m, 4H), 6.23 (s,
1H), 7.65 (d, J¼8.7 Hz, 1H), 7.91 (dd, J¼8.7, 2.4 Hz, 1H), 8.27 (d,
793, 747, 694 cmꢁ1. 1H NMR (CDCl3)
d
3.06 (s, 3H), 4.56 (s, 2H), 6.07
J¼2.4 Hz, 1H); 13C NMR (CDCl3)
d 46.1, 50.3, 54.2, 98.4, 115.56,
(s, 1H), 7.26–7.36 (m, 5H), 7.61 (d, J¼8.7 Hz, 1H), 7.85 (dd, J¼8.7,
115.59, 121.7, 138.7, 141.0, 145.9, 160.1; m/z (EI): 277 (Mþ, 100%), 220
(14), 206, (13), 192 (34), 160 (14), 146 (9), 133 (16); HRMS (ESI) calcd
for C13H16N3O2S [MþH]þ 278.0959, found 278.0963.
2.1 Hz,1H), 8.21 (d, J¼2.1 Hz,1H); 13C NMR (CDCl3)
d 39.7, 59.0, 95.6,
114.58, 114.66, 121.4, 127.2, 127.8, 128.8, 136.5, 138.0, 141.8, 145.9,
159.3; m/z (EI) 298 (Mþ, 20%), 91 (100); HRMS (ESI) calcd for
C16H15N2O2S [MþH]þ 299.0843, found 299.0854.
4.4.25. Ethyl 2-(1-(2-chlorophenyl)ethylidene)hydrazinecarboxylate
(24). A mixture of 1-(2-chlorophenyl)ethanone 23 (3 g,
19.4 mmol), ethyl carbazate (2.42 g, 23.3 mmol), and one drop of
AcOH in 40 mL of EtOH/H2O (1:1) was refluxed for 3 h and left
overnight at rt. The precipitate was filtered, washed with EtOH/H2O
(1:1) and dried affording 2.19 g (47%) of 24 as white crystals, mp
4.4.19. N-tert-Butyl-5-nitrobenzo[b]thiophen-2-amine
(14s). Purified by column chromatography (SiO2, CHCl3/Hexane
(1:1)). Yellow crystals, 0.20 g (39%), mp 114–115 ꢀC. IR (neat): 3347,
3109, 2970, 1508, 1469, 1335, 1204, 1060, 903, 827, 796 cmꢁ1 1H
.
NMR (CDCl3)
d
1.42 (s, 9H), 4.18 (br s, 1H), 6.31 (s, 1H), 7.61 (d,
130–131 ꢀC. 1H NMR (CDCl3)
4.33 (q, J¼7.1 Hz, 2H), 7.26–7.30 (m, 2H), 7.35–7.38 (m, 1H), 7.41–
d
1.34 (t, J¼7.1 Hz, 3H), 2.22 (s, 3H),
J¼8.7 Hz, 1H), 7.90 (dd, J¼8.7, 2.1 Hz, 1H), 8.26 (d, J¼2.1 Hz, 1H); 13C
NMR (CDCl3)
d
29.3, 53.6, 101.2,115.3,115.6, 121.4, 138.9, 141.1, 145.8,
7.44 (m, 1H), 7.93 (br s, 1H, NH); 13C NMR (CDCl3)
d 14.6, 16.8, 62.2,
153.8; m/z (EI) 250 (Mþ, 37%), 194 (100), 148 (46), 121 (12), 57 (69);
126.9, 129.7, 129.9, 130.5, 132.3, 138.8, 149.5; m/z (EI) 240 (Mþ, 13%),
205 (33), 161 (30), 152 (26), 133 (100), 126 (25), 111 (7); HRMS (EI)
calcd for C11H13ClN2O2 [Mþ] 240.0666, found 240.0664.
HRMS (EI) calcd for C12H14N2O2S [Mþ] 250.0776, found 250.0775.
4.4.20. Ethyl
2-(5-nitrobenzo[b]thiophen-2-ylamino)acetate
(14t). Purified by column chromatography (SiO2, CHCl3/Hexane
4.4.26. 4-(2-Chlorophenyl)-1,2,3-thiadiazole (25). A solution of 24
(2.0 g, 8.32 mmol) in 6 mL of SOCl2 was refluxed for 2 h, cooled and
poured into water. The precipitate was thoroughly washed with
water and dried affording 1.3 g (79%) of pure 25 as light-brown
(2:1)). Yellow crystals, 0.052 g (9%), mp 163–164 ꢀC. 1H NMR
(CDCl3)
d
1.33 (t, J¼7.2 Hz, 3H), 4.01 (d, J¼5.1 Hz, 2H), 4.29 (q,
J¼7.2 Hz, 2H), 4.95 (br t, 1H), 6.13 (s, 1H), 7.62 (d, J¼8.7 Hz, 1H), 7.91